In summary, we report a clinical P. aeruginosa isolate from China co-harbouring blaKPC-2 and blaNDM-9. The emergence of multi-carbapenemase-producing strains poses a serious threat to antimicrobial therapy, underscoring the need for continuous clinical surveillance.
Huang et al. (Wed,) studied this question.